Laurie Toich, Assistant Editor

Hospira recalls vancomycin hydrochloride injection due to particulate matter contamination.

Clinical trial holds were placed on pembrolizumab to treat multiple myeloma following adverse event concerns.

Pembrolizumab (Keytruda) combination therapy may increase mortality risk among multiple myeloma patients.

High-dose vitamin C found to revert leukemia stem cells with a specific mutation back to normal cells.

Younger men are less likely to be aware of and receive treatment for hypertension.

A new class of neurons expand the knowledge of pain prevention.

Communicating with a psychologist via email improved stress and depression symptoms among parents of children with cancer.

Seven or more years of oral contraceptive use was linked to a 19% reduced risk of rheumatoid arthritis.

Targeting the arginase 2 enzyme observed to reduce the growth of pancreatic cancer.

Pancreatic islet cells implanted under the skin may normalize blood glucose levels in type 1 diabetes patients.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Patients who were adherent to oral diabetes drugs spent $500 less on health care compared with nonadherent patients.

Antibacterial regimen of meropenem-vaborbactam showed superior efficacy and comparable tolerability compared with piperacillin/tazobactam (Zosyn).

Patients who were not adherent to oral diabetes drugs had 1.3 times higher medical costs.

Amyloid plaques accumulate in the retinas of patients with Alzheimer’s disease.

Epigenetic drugs may reduce viral reactivation of herpes and other viruses.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, talks about the importance of care coordination.

Increasing sleep by a half hour significantly reduced body weight and insulin resistance.

Top news of the day from across the healthcare landscape.

Benznidazole granted accelerated approval for use in children aged 2 to 12 years with Chagas disease.

Attendees of the National Association of Specialty Pharmacy annual meeting have the chance to see the nation’s capital during downtime.

A lawsuit that alleged CVS conspired with PBMs to increase costs was dropped on the grounds of incorrect information presented in the case.

Boehringer said they also plan to seek approval for an auto-injector of the biosimilar to expand options for patients.

Cyltezo is the first biosimilar developed by Boehringer Ingelheim to be approved by the FDA.

Cyltezo approved for the same indications as Humira, including rheumatoid arthritis, psoriatic arthritis, and Crohn’s disease.

Abnormal eating times shown to increase susceptibility to daytime ultraviolet rays.

Alcohol consumption results in more than $150 million spent on breast cancer annually.

A selective assessment method may lead to earlier diagnosis and treatment of Alzheimer’s disease.

Top news of the day from across the healthcare landscape.